ArticleCurrent oncology (Toronto, Ont.)2012

A personalized approach to treatment: use of EGFR tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer in Canada.

V Hirsh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.